ALN-AT3SC

ALN-AT3SC Uses, Dosage, Side Effects, Food Interaction and all others data.

ALN-AT3SC is under investigation in clinical trial NCT02554773 (An Open-label Extension Study of an Investigational Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B).

Trade Name ALN-AT3SC
Generic Fitusiran
Fitusiran Other Names ALN-AT3SC, Fitusiran
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
ALN-AT3SC
ALN-AT3SC

Innovators Monograph

You find simplified version here ALN-AT3SC


*** Taking medicines without doctor's advice can cause long-term problems.
Share